Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$7.62 USD
+0.73 (10.60%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $7.53 -0.09 (-1.18%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -2.15 |
EPS Last Quarter | 0.75 |
Last EPS Surprise | 118.75% |
ABR | 1.00 |
Earnings ESP
|
120.93% |
---|---|
Current Year | -8.20 |
Next Year | -12.54 |
EPS (TTM) | -20.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.00M | 1.00M | 2.60M | 4.00M |
# of Estimates | 1 | 1 | 3 | 1 |
High Estimate | 1.00M | 1.00M | 4.00M | 4.00M |
Low Estimate | 1.00M | 1.00M | 1.76M | 4.00M |
Year ago Sales | 2.15M | 2.68M | 14.44M | 2.60M |
Year over Year Growth Est. | -53.49% | -62.69% | -81.99% | 53.79% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.15 | -1.47 | -8.20 | -12.54 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -4.40 | -2.41 | -11.21 | -11.28 |
High Estimate | 0.45 | -0.26 | -4.64 | -8.50 |
Low Estimate | -4.40 | -2.41 | -11.21 | -17.84 |
Year ago EPS | -10.25 | -5.50 | -34.00 | -8.20 |
Year over Year Growth Est. | 79.02% | 73.27% | 75.88% | -52.93% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.15 | -1.47 | -8.20 | -12.54 |
7 Days Ago | -2.15 | -1.47 | -8.20 | -12.54 |
30 Days Ago | -2.13 | -1.47 | -8.15 | -12.43 |
60 Days Ago | -1.00 | -1.00 | -6.63 | -13.00 |
90 Days Ago | -4.25 | -4.50 | -18.25 | -17.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.45 | -0.26 | -4.64 | -17.84 |
Zacks Consensus Estimate | -2.15 | -1.47 | -8.20 | -12.54 |
Earnings ESP | 120.93% | 82.35% | 43.42% | -42.27% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.75 | -5.50 | -5.50 | -10.25 | NA |
Estimate | -4.00 | -4.75 | -6.75 | -12.00 | NA |
Difference | 4.75 | -0.75 | 1.25 | 1.75 | 1.75 |
Surprise | 118.75% | -15.79% | 18.52% | 14.58% | 34.02% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more